What are the recommended antibiotics for treating Enterococcus urinary tract infections (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Antibiotics for Enterococcus UTI

For Enterococcus urinary tract infections, nitrofurantoin (100mg twice daily for 5 days) and fosfomycin (3g single dose) are the first-line treatments for uncomplicated lower UTIs, while ampicillin is the drug of choice for ampicillin-susceptible strains. 1

First-Line Treatment Options

Uncomplicated Lower UTIs

  • Nitrofurantoin: 100mg twice daily for 5 days 1
  • Fosfomycin: 3g single dose 1
  • Trimethoprim-sulfamethoxazole: 160/800mg twice daily for 3 days (if susceptible) 1

Ampicillin-Susceptible Enterococcus

  • Ampicillin: First choice for susceptible strains 2, 3
    • Even for isolates with MICs above susceptibility breakpoints, aminopenicillins may be effective for lower UTIs due to high urinary concentrations 3

Treatment for Resistant Strains

Vancomycin-Resistant Enterococcus (VRE)

  • Linezolid: Reserve for confirmed upper/bacteremic VRE UTIs with ampicillin resistance 2
  • Daptomycin: Alternative for upper/bacteremic VRE UTIs 2

High-Level Aminoglycoside Resistance

  • Avoid aminoglycosides if high-level resistance is detected (MIC ≥2,000 μg/ml) 4
  • Consider alternative agents based on susceptibility testing 1

Treatment Duration

  • 5-7 days for uncomplicated UTIs 1
  • 7-14 days for complicated infections or pyelonephritis 5, 1

Important Considerations

Susceptibility Testing

  • Always obtain urine culture and susceptibility testing to guide therapy 6
  • Local resistance patterns should inform empiric therapy choices 1
  • Enterococci have intrinsic resistance to cephalosporins, making these ineffective 4, 7

Resistance Patterns

  • E. faecalis is generally more susceptible to antibiotics than E. faecium 8
  • Increasing resistance to ampicillin/sulbactam has been observed over time 7
  • All enterococcal species have intrinsic resistance to cephalosporins 4

Special Situations

  • For complicated or upper tract infections, parenteral therapy may be necessary initially 5
  • Avoid nitrofurantoin in patients with pyelonephritis or urosepsis as it doesn't achieve adequate serum concentrations 5

Treatment Algorithm

  1. Obtain urine culture and susceptibility testing
  2. For uncomplicated lower UTI while awaiting results:
    • Nitrofurantoin 100mg twice daily, or
    • Fosfomycin 3g single dose
  3. Once susceptibility results available:
    • If ampicillin-susceptible: Use ampicillin
    • If ampicillin-resistant but nitrofurantoin/fosfomycin-susceptible: Continue with either agent
    • If VRE or multi-drug resistant: Consider linezolid or daptomycin for upper/bacteremic infections
  4. Treatment duration:
    • 5 days for uncomplicated lower UTI
    • 7-14 days for complicated infections or pyelonephritis

Remember that enterococci are intrinsically resistant to cephalosporins, and inappropriate antibiotic use has contributed to increasing resistance patterns. Always base final treatment decisions on culture and susceptibility results to ensure optimal outcomes.

References

Guideline

Treatment of E. faecalis Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Aminopenicillins for treatment of ampicillin-resistant enterococcal urinary tract infections.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2022

Research

The life and times of the Enterococcus.

Clinical microbiology reviews, 1990

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.